Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?-Reference-Cited by-同舟云学术

Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?

Published:2003-09 Issue:9386 Volume:362 Page:755-757
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

White Harvey D

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients;Flather;Lancet,2000

2. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published erratum appears in N Engl J Med. 2000. 342: 748];N Engl J Med,2000

3. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions;Yusuf;Lancet,1992

4. Myocardial infarction redefine—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction;Eur Heart J,2000

5. Blood pressure, stroke, and coronary heart disease: Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias;MacMahon;Lancet,1990

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin‐Converting Enzyme Inhibitors;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

2. Inhibitors of the renin-angiotensin-aldosterone system;Drugs for the Heart;2013

3. NHG-Standaard Beleid na een doorgemaakt myocardinfarct;NHG- Standaarden voor de huisarts 2011;2011

4. Angiotensin‐Converting Enzyme Inhibitors;Burger's Medicinal Chemistry and Drug Discovery;2010-09-15

5. Angiotensin-converting enzymes and drug discovery in cardiovascular diseases;Drug Discovery Today;2010-05